Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 1999;45:168-169; doi:10.1136/gut.45.2.168
Copyright © 1999 BMJ Publishing Group Ltd & British Society of Gastroenterology.
Gut 1999;45:168-169 ( August )

Commentary

See article on page 284

HBV + HCV = HCC?

The first 150 words of the full text of this article appear below.

Most people infected with hepatitis C virus (HCV) develop a chronic infection with persistent viraemia and are at risk of progressive liver damage. However, the outcome of chronic HCV infection is extremely variable and is influenced by many factors, including HCV genotype, HCV viral load, route of infection, age at infection, sex, and alcohol consumption. Ultimately, it is the progression to cirrhosis that is the key determinant of both morbidity and mortality1 and a better understanding of additional influences likely to promote this development is needed.

Both hepatitis B virus (HBV) and HCV are transmitted parenterally and coinfection is not uncommon, particularly in intravenous drug users and in countries with a high prevalence of HBV infection.2 Coinfection with evidence of chronic HBV and HCV seems to result in more severe liver disease than either infection alone,3 with an increased risk of liver cancer2 and probably an increased risk of fulminant . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan
H Marusawa, Y Osaki, T Kimura, K Ito, Y Yamashita, T Eguchi, M Kudo, Y Yamamoto, H Kojima, H Seno, F Moriyasu, and T Chiba
Gut 1999 45: 284-288. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Lee, N. Y., Choi, H.-K., Shim, J.-H., Kang, K.-W., Dong, Z., Choi, H. S. (2009). The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation. Carcinogenesis 30: 671-681 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs